Evidence map›Paper›PMID 41873764›Full record

ArticleNucleic acids research2026

High-throughput methods enabling random duplications, deletions, or nucleotide-constrained mutagenesis of entire DNA motifs.

Marcus Wäneskog, Knud Nor Nielsen, Marcus Deichmann, Samuel Alan Bradley, Michael Krogh Jensen, Emil Damgaard Jensen

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marcus WäneskogThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.ORCID 0000-0003-2480-5631
Knud Nor NielsenThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.ORCID 0000-0002-5777-1485
Marcus DeichmannThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.ORCID 0000-0003-3540-0576
Samuel Alan BradleyThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.
Michael Krogh JensenThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.ORCID 0000-0001-7574-4707
Emil Damgaard JensenThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.ORCID 0000-0002-8280-0946

Funding

Novo Nordisk Foundation NNF20CC0035580Wenner-Gren Foundations
6 · The paper itself

Abstract

Currently available random and untargeted DNA mutagenesis techniques are limited by both the number of consecutive nucleotides that can be mutated and by the type of accessible mutations. These methodologies also create multiple different mutated sites within each DNA sequence-of-interest, which significantly confounds any precise and high-throughput phenotype-to-genotype mapping. Here, we describe two unique and cell-independent DNA mutagenesis methods that enable either a single random and small-scale (1-30 nt) duplication, deletion, or insertion of an entire DNA motif (RADDIM), or nucleotide-constrained mutagenesis of random DNA regions spanning >8 consecutive nucleotides (NSM). By utilizing these mechanistically unique methods, we randomly duplicated and deleted cryptic regulatory DNA elements in two yeast promoters (pACT1 and pTEF1) to change their transcriptional expression. We randomly mutated the protein structure of an inactivated β-lactamase (TEM-1) to restore its enzymatic function by generating multiple, consecutive in-frame InDels. We also selectively mutated the AT-content and introduced TATA-box-like sequences and homopolymeric mutations, within random DNA regions. Collectively, RADDIM and NSM allow for an unprecedented level of bespoke DNA mutagenesis at random DNA locations, expanding the toolkit for genetic engineering, directed evolution, and the functional mapping of novel protein structures and cryptic regulatory DNA motifs.

Indexed as

MutagenesisNucleotide Motifsbeta-LactamasesINDEL MutationPromoter Regions, GeneticSaccharomyces cerevisiaeSequence Deletionbeta-Lactamasesbeta-lactamase TEM-1

Identifiers

PMID41873764
PMCPMC13010153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.